PMAM
PTLA

Picton Mahoney Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Picton Mahoney Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-500
Closed -$14K – 376
2014
Q4 		$14K Buy
+500
New +$13.9K ﹤0.01% 318

Other funds holding PTLA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Picton Mahoney Asset Management's PTLA Position: Q1 2015 in Review

Picton Mahoney Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2015, closing a stake of 500 shares — an estimated $14K sold.

Picton Mahoney Asset Management first reported a position in PTLA in Q4 2014 and held it in 1 quarter. The position peaked at $14K in Q4 2014. 160 funds tracked by Wall St. Rank hold PTLA as of Q1 2015.

  • Picton Mahoney Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 500 Portola Pharmaceuticals, Inc. shares in Q1 2015, an estimated $14K.
  • Picton Mahoney Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and held it in 1 quarter.
  • Picton Mahoney Asset Management's Portola Pharmaceuticals, Inc. position peaked at $14K in Q4 2014.
  • 160 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2015.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2015, filed 29 Apr 2015.